AJP - GI Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 281: G393-G404, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VanPatten, S.
Right arrow Articles by Cohen, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VanPatten, S.
Right arrow Articles by Cohen, D. E.
Vol. 281, Issue 2, G393-G404, August 2001

Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance

Sonya VanPatten1, Narasimha Ranginani2, Sarah Shefer3, Lien B. Nguyen3, Luciano Rossetti2, and David E. Cohen1,2

Departments of 1 Biochemistry and 2 Medicine, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461; and 3 Department of Medicine and Liver Center, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103

Human obesity is associated with elevated plasma leptin levels. Obesity is also an important risk factor for cholesterol gallstones, which form as a result of cholesterol hypersecretion into bile. Because leptin levels are correlated with gallstone prevalence, we explored the effects of acute leptin administration on biliary cholesterol secretion using lean (FA/-) and obese (fa/fa) Zucker rats. Zucker (fa/fa) rats become obese and hyperleptinemic due to homozygosity for a missense mutation in the leptin receptor, which diminishes but does not completely eliminate responsiveness to leptin. Rats were infused intravenously for 12 h with saline or pharmacological doses of recombinant murine leptin (5 µg · kg-1 · min-1) sufficient to elevate plasma leptin concentrations to 500 ng/ml compared with basal levels of 3 and 70 ng/ml in lean and obese rats, respectively. Obesity was associated with a marked impairment in biliary cholesterol secretion. In biles of obese compared with lean rats, bile salt hydrophobicity was decreased whereas phosphatidylcholine hydrophobicity was increased. High-dose leptin partially normalized cholesterol secretion in obese rats without altering lipid compositions, implying that both chronic effects of obesity and relative resistance to leptin contributed to impaired biliary cholesterol elimination. In lean rats, acute leptin administration increased biliary cholesterol secretion rates. Without affecting hepatic cholesterol contents, leptin downregulated hepatic activity of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, upregulated activities of both sterol 27-hydroxylase and cholesterol 7alpha -hydroxylase, and lowered plasma very low-density lipoprotein cholesterol concentrations. Increased biliary cholesterol secretion in the setting of decreased cholesterol biosynthesis and increased catabolism to bile salts suggests that leptin promotes elimination of plasma cholesterol.

obesity; liver; bile salts; phospholipids; lipoproteins


This article has been cited by other articles:


Home page
 DiabetesHome page
J. L. Estall, M. Kahn, M. P. Cooper, f. M. Fisher, M. K. Wu, D. Laznik, L. Qu, D. E. Cohen, G. I. Shulman, and B. M. Spiegelman
Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha} Expression
Diabetes, July 1, 2009; 58(7): 1499 - 1508.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. K. Wu and D. E. Cohen
Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G456 - G461.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Tiemann, Z. Han, R. Soccio, J. Bollineni, S. Shefer, E. Sehayek, and J. L. Breslow
Cholesterol feeding of mice expressing cholesterol 7{alpha}-hydroxylase increases bile acid pool size despite decreased enzyme activity
PNAS, February 17, 2004; 101(7): 1846 - 1851.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Xiong, K. Yoshinari, K. L. R. Brouwer, and M. Negishi
Role of Constitutive Androstane Receptor in the In Vivo Induction of Mrp3 and CYP2B1/2 by Phenobarbital
Drug Metab. Dispos., August 1, 2002; 30(8): 918 - 923.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
N. Mendez-Sanchez, V. Gonzalez, A. C. King-Martinez, H. Sanchez, and M. Uribe
Plasma Leptin and the Cholesterol Saturation of Bile Are Correlated in Obese Women after Weight Loss
J. Nutr., August 1, 2002; 132(8): 2195 - 2198.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. Bouchard, D. Johnson, T. Carver, B. Paigen, and M. C. Carey
Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk
J. Lipid Res., July 1, 2002; 43(7): 1105 - 1113.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online